Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 2 August 2019. Bryan Hanson.

Executive Summary

Zimmer Biomet says its long-term plan to return to steady growth is ahead of schedule. See what company CEO Bryan Hanson said about it here.

“We’ve increased accountability and strengthened our ‘ZB spirit’ across the organization as a result of our new structure, new leadership team and through a relentless focus on culture in connection to our mission. We continue to drive efficiency throughout our supply chain to ensure that we meet increased demand for our products and drive confidence in our sales team.” – Bryan Hanson, CEO, Zimmer Biomet Holdings Inc.

Click here for a free trial of Medtech Insight

 
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT125449

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel